The association of age with rate of cognitive decline in elderly individuals residing in supporting care facilities

Alzheimer Disease and Associated Disorders

Volumn 25, Issue 4, 2011, Pages 312-316

  Ravona Springer, Ramit ^a   Luo, Xiaodong ^b   Schmeidler, James ^b   Wysocki, Michael ^b   Lesser, Gerson T ^c   Rapp, Michael A ^d   Dahlman, Karen ^b   Grossman, Hillel T ^b   Haroutunian, Vahram ^b   Beeri, Michal Schnaider ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Jewish Home and Hospital   (United States)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Age; assisted living; cognitive decline; dementia stage; nursing home; rate

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CLINICAL DEMENTIA RATING; DEMENTIA; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; NURSING HOME; PREDICTIVE VALUE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RACE;

AGED; AGED, 80 AND OVER; AGING; BRIEF PSYCHIATRIC RATING SCALE; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HOMES FOR THE AGED; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NURSING HOMES;

EID: 81855194394     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31820d880e     Document Type: Article

References (33)

1. Rockwood K, Stadnyk K. The prevalence of dementia in the elderly: a review. Can J Psychiatry. 1994;39:253-257. (Pubitemid 24227315)
2. Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am JPsychiatry. 2010;151:390-396.
3. Doody RS, Massman P, Dunn JK. A method for estimating progression rates in Alzheimer disease. Arch Neurol. 2001;58: 449-454. (Pubitemid 32217462)
4. Ruitenberg A, Kalmijn S, de Ridder MA, et al. Prognosis of Alzheimer's disease: the Rotterdam Study. Neuroepidemiology. 2001;20:188-195. (Pubitemid 32718876)
5. Luchsinger JA. Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective. Eur J Pharmacol. 2008;585:119-129.
6. Schnaider BM, Goldbourt U, Silverman JM, et al. Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology. 2004;63:1902-1907. (Pubitemid 39532388)
7. Launer LJ. Overview of incidence studies of dementia conducted in Europe. Neuroepidemiology. 1992;11(suppl 1): 2-13.
8. Mc Carten JR, Hemmy LS, Rottunda SJ, et al. Patient age influences recognition of Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 2008;63:625-628.
9. Mielke MM, Rosenberg PB, Tschanz J, et al. Vascular factors predict rate of progression in Alzheimer disease. Neurology. 2007;69:1850-1858. (Pubitemid 350071146)
10. Small BJ, Viitanen M, Winblad B, et al. Cognitive changes in very old persons with dementia: the influence of demographic, psychometric, and biological variables. J Clin Exp Neuropsy-chol. 1997;19:245-260. (Pubitemid 27261215)
11. Friedman SM, Mendelson DA, Bingham KW, et al. Hazards of hospitalization: residence prior to admission predicts out-comes. Gerontologist. 2008;48:537-541.
12. Golant SM. Do impaired older persons with health care needs occupy US assisted living facilities? An analysis of six national studies. J Gerontol B Psychol Sci Soc Sci. 2004;59B:S68-S79. (Pubitemid 38326340)
13. Macdonald AJ, Carpenter GI. The recognition of dementia in "non-EMI" nursing home residents in South East England. Int JGeriatr Psychiatry. 2003;18:105-108. Ref ID: 122. (Pubitemid 36236231)
14. Folstein MF, Folstein SE, Mc Hugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. JPsychiatr Res. 1975;12:189-198.
15. Morris J. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 2010;43:2412-2414.
16. Marin DB, Flynn S, Mare M, et al. Reliability and validity of a chronic care facility adaptation of the clinical dementia rating scale. Int J Geriatr Psychiatry. 2001;16:745-750 (Pubitemid 32834112)
17. Alzheimer's Disease Research Center (ADRC). (http:// www.alz.washington. edu/NONMEMBER/cdr2.html). 2010.
18. Saxton J, Snitz BE, Lopez OL, et al. Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia. J Neurol Neurosurg Psychiatry. 2009;80:737-743.
19. Jones RN, Gallo JJ. Education bias in the mini-mental state examination. Int Psychogeriatr. 2001;13:299-310. (Pubitemid 33101669)
20. Mc Nabney MK, Samus QM, Lyketsos CG, et al. The spectrum of medical illness and medication use among residents of assisted living facilities in central Maryland. J Am Med Dir Assoc. 2008;9:558-564.
21. Magsi H, Malloy T. Underrecognition of cognitive impairment in assisted living facilities. JAm Geriatr Soc. 2005;53:295-298. (Pubitemid 41632557)
22. Zimmerman S, Gruber-Baldini AL, Sloane PD, et al. Assisted living and nursing homes: apples and oranges? Gerontologist. 2003;43:107-117. (Pubitemid 41185037)
23. Wilson RS, Mc Cann JJ, Li Y, et al. Nursing home placement, day care use, and cognitive decline in Alzheimer's disease. Am J Psychiatry. 2007;164:910-915. (Pubitemid 46972906)
24. Mortimer JA. Brain reserve and the clinical expression of Alzheimer's disease. Geriatrics. 1997;52(suppl 2):S50-S53.
25. Galasko DR, Gould RL, Abramson IS, et al. Measuring cognitive change in a cohort of patients with Alzheimer's disease. Stat Med. 2000;19:1421-1432 (Pubitemid 30346235)
26. Ravona-Springer R, Luo X, Schmeidler J, et al. Diabetes is associated with increased rate of cognitive decline in ques-tionably demented elderly. Dement Geriatr Cogn Disord. 2010; 29:68-74.
27. Guk-Hee S, Young-Su J, Byeong KY, et al. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline. Int J Geriatr Psychiatry. 2010;19:817-824.
28. Bruandet A, Richard F, Bombois S, et al. Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry. 2009;80:133-139.
29. Mungas D, Reed BR, Ellis WG, et al. The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Arch Neurol. 2001;58: 1243-1247. (Pubitemid 32751743)
30. Drachman DA. Aging of the brain, entropy, and Alzheimer disease. Neurology. 2006;67:1340-1352. (Pubitemid 44632055)
31. Backman L, Jones S, Small BJ, et al. Rate ofcognitive decline in preclinical Alzheimer's disease: the role of comorbidity. J Gerontol B Psychol Sci Soc Sci. 2003;58:228-236.
32. Sliwinski MJ, Hofer SM, Hall C, et al. Modeling memory decline in older adults: the importance ofpreclinical dementia, attrition, and chronological age. Psychol Aging. 2003;18: 658-671. (Pubitemid 37543429)
33. Rascovsky K, Salmon DP, Lipton AM, et al. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology. 2005;65:397-403. (Pubitemid 41099802)